Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Dec 7 2023

Full Issue

Research Roundup: Lung, Colorectal Cancers; Covid; Racism In The NEJM

Each week, KFF Health News compiles a selection of health policy studies and briefs.

ScienceDaily: A Type Of Allergy Medicine Might Help Treat Lung Cancer 

Researchers have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).  And in an early parallel study in humans, combining immunotherapy with dupilumab -- an Interleukin-4 (IL-4) receptor-blocking antibody widely used for treating allergies and asthma -- boosted patients' immune systems, with one out of the six experiencing significant tumor reduction. (The Mount Sinai Hospital / Mount Sinai School of Medicine, 12/6)

New England Journal of Medicine: Sotorasib Plus Panitumumab In Refractory Colorectal Cancer With Mutated KRAS G12C

In this phase 3 trial of a KRAS G12C inhibitor plus an EGFR inhibitor in patients with chemorefractory metastatic colorectal cancer, both doses of sotorasib in combination with panitumumab resulted in longer progression-free survival than standard treatment. (Fakih et al, 12/7)

CIDRAP: Study Spotlights How COVID-19 Admissions Burdened ICUs

COVID-19 hospital admissions greatly affected occupancy rates of intensive care units (ICUs) across 45 US states, according to a new study in JAMA Health Forum. The study looked at hospital occupancy rates for each week in 2020 at 3,960 hospitals, as recorded by the Healthcare Cost and Utilization Project State Inpatient Databases, and compared the number of occupied beds to the same week in 2019. Each week was categorized based on the number of COVID-19 admissions per 100 beds, with 15 admissions per 100 considered high COVID-19 activity, and less than 1 per 100 considered low. (Soucheray, 12/4)

CIDRAP: Excess Deaths Soared In US Prisons During First Year Of COVID-19

The first year of the COVID-19 pandemic led to a dramatic increase in deaths among jailed Americans, a new study in Science Advances shows, with deaths among prisoners 3.4 times greater than in the general population in 2020. Overall, total mortality increased 77% in 2020 relative to 2019, the authors said. (Soucheray, 12/4)

Stat: New England Journal Of Medicine Addresses Racist History, Slavery 

The New England Journal of Medicine, the world’s oldest continually published medical journal, publicly reckoned with its history and complicity surrounding slavery and racism Wednesday, publishing the first of a series of essays by independent historians on the role the prestigious publication has played in perpetuating racist thinking in medicine that continues to this day. (McFarling, 12/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF